{
    "fund_name": "WisdomTree CAC 40 3x Daily Short",
    "type": "ETP",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": true,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "3x daily leverage",
        "Inverse exposure",
        "Synthetic replication",
        "Shorting mechanism",
        "Daily reset compounding effect",
        "High risk profile (7/7)",
        "Complex index tracking (CAC 40 X3 Short GR)",
        "Potential for significant tracking error",
        "No capital protection",
        "Unlimited loss potential"
    ],
    "classification": "complex",
    "confidence": 95,
    "supporting_data": "The WisdomTree CAC 40 3x Daily Short ETP is clearly classified as complex under MiFID II due to multiple factors:1. Leverage and Inverse Exposure: The product provides 3x daily short exposure to the CAC 40 index, which is a highly complex strategy that resets daily and can lead to significant compounding effects that are difficult for retail investors to understand.2. Synthetic Replication: The product uses derivative instruments (likely swaps) to achieve its exposure, as indicated by the 'fully collateralised' structure and references to futures contracts in the benchmark.3. High Risk Profile: The product is classified as 7/7 on the risk scale, indicating very high potential losses.4. Complex Index Tracking: The underlying index (CAC 40 X3 Short GR) is itself a complex construction that involves shorting and leverage, which compounds the complexity.5. Short-Term Holding Recommendation: The recommended holding period is just 1 day, which is highly unusual and indicates the product is designed for very short-term trading rather than long-term investment.6. Potential for Unlimited Losses: The product explicitly states that investors could lose all of their investment, which is a hallmark of complex products.7. Comprehension Warning: The KIID explicitly states 'You are about to purchase a product that is not simple and may be difficult to understand,' which is a strong indicator of complexity under MiFID II.While the product is UCITS-eligible, the combination of these factors clearly places it in the 'complex' category. The use of derivatives is not merely for efficient portfolio management but is fundamental to the product's strategy, making it inherently complex. The daily reset mechanism and compounding effects are particularly problematic for retail investors to understand, further supporting the complex classification.",
    "counter_argument": "One might argue that the product is fully collateralised and UCITS-eligible, which could suggest lower complexity. However, the UCITS eligibility does not negate the fundamental complexity of the product's strategy and structure. The collateralisation merely reduces counterparty risk but does not simplify the underlying investment strategy, which remains highly complex due to the leverage, inverse exposure, and daily reset mechanism.",
    "overriding_reason": "The overriding reason for the complex classification is the combination of 3x daily leverage, inverse exposure, and the compounding effects of daily resets, which create a highly complex risk profile that is difficult for retail investors to understand and manage. The product's design is inherently complex, regardless of collateralisation or UCITS status."
}